- Coloplast
-
Coloplast A/S Type Publicly traded Aktieselskab Traded as OMX: COLO B Industry Health care Founded 1957 Headquarters Humlebæk, Denmark Key people Lars Rasmussen (President and CEO), Michael Pram Rasmussen (Chairman) Products Ostomy bags, continence products, dressings Revenue DKK 10.17 billion (2010/2011)[1] Operating income DKK 2.581 billion (2010/2011)[1] Profit DKK 1.819 billion (2010/2011)[1] Total assets DKK 9.218 billion (September 2011)[1] Total equity DKK 4.478 billion (September 2011)[1] Employees 7,330 (FTE, average 2010/2011)[1] Website www.coloplast.com Coloplast is an international company that develops, manufactures and markets medical devices and services related to ostomy, urology and continence, and wound treatment.
Coloplast was founded in 1957, employs more than 7,000 people and operates around the world.[2] It has its headquarters in Humlebæk, Denmark. Its U.S. headquarters is in Minneapolis, Minnesota.
External links
References
- ^ a b c d e f "Annual Report 2010/2011". Coloplast. http://www.coloplast.com/About/news/Documents/Annual%20report%202010-11.pdf. Retrieved 15 November 2011.
- ^ [1]
OMX Copenhagen 20 companies of Denmark
A.P. Møller-Mærsk · Carlsberg · Chr. Hansen · Coloplast · D/S Norden · Danske Bank · DSV · FLSmidth & Co. · GN Store Nord · Lundbeck · NKT Holding · Novo Nordisk · Novozymes · Pandora · Sydbank · TDC · Topdanmark · Tryg · Vestas Wind Systems · William Demant
Categories:- Companies listed on the OMX exchanges
- Health care companies of Denmark
- Danish company stubs
Wikimedia Foundation. 2010.